Company Description

ImmunoRestoration ImmunoRestoration’s core technology (Immune Conditioning via Activated Innate (autologous) Transfer - ICAIT™ ) is a novel, integrated dendritic cell-based immunization system to overcome some of the known obstacles facing anti-cancer vaccines:  Breakthrough finding: HER-2 pulsed dendritic cell vaccine can eliminate HER-2 expression and impact both invasive breast cancer as well as ductal carcinoma in situ."